Newman Dignan & Sheerar, Inc. Clearside Biomedical, Inc. Transaction History

Newman Dignan & Sheerar, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$0.68 - $1.18 $19,055 - $33,067	28,023 New	28,023 $32,000
Q3 2022 Oct 18, 2022	BUY	$1.08 - $1.83 $29,184 - $49,452	27,023 New	27,023 $31,000
Q2 2022 Aug 03, 2022	SELL	$1.3 - $2.49 $35,129 - $67,287	-27,023 Closed	0 $0
Q1 2022 Apr 14, 2022	BUY	$1.35 - $2.88 $1,620 - $3,456	1,200 Added 4.65%	27,023 $62,000
Q4 2021 Jan 18, 2022	BUY	$2.72 - $5.72 $11,696 - $24,596	4,300 Added 19.98%	25,823 $71,000
Q3 2021 Oct 07, 2021	BUY	$4.83 - $7.2 $103,956 - $154,965	21,523 New	21,523 $129,000
Q2 2021 Jul 28, 2021	SELL	$2.32 - $5.38 $53,413 - $123,863	-23,023 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$2.24 - $4.25 $51,571 - $97,847	23,023 New	23,023 $57,000

13.4M

17.6K

100

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Newman Dignan & Sheerar, Inc., based on Form 13F filings with the SEC.

Stay updated on Newman Dignan & Sheerar, Inc. with notifications on news.